As of April 8, 2016, articles in Neurology® Genetics can be searched using PubMed. Launched in 1996, PubMed is a search engine that accesses citations and abstracts of more than 26 million articles. Its primary sources include the MEDLINE database, which was started in the 1960s, and biomedical and life sciences journal articles that date back to 1946. In addition, PubMed accesses other sources, for example, citations to those life sciences journals that submit full-text articles to PubMed Central (PMC). PubMed Central was launched in 2000 as a free archive of biomedical and life science journals.
To be listed in PMC, a journal has to meet specific scientific and technical standards. These include a review of the scientific quality of published manuscripts and editorial team, as well as an assessment of the technical quality of the digital files. The decision regarding acceptance is based on published criteria and expert consultation. The editorial staff and Associate Editors of Neurology: Genetics deserve my thanks for achieving this milestone in the shortest possible time.
As of June 10, 2016, there are 80 articles listed in PubMed that can be found using the search term “Neurol Genet” [Journal]. All authors and editorialists who contributed to the first 7 issues can rest assured that electronic searches will lead investigators to their contributions. Our eighth issue adds 2 editorials, 4 full-length articles, and 4 Clinical/Scientific Notes.
Harris and colleagues1 describe a large multicenter observational study of patients with dysferlinopathy. They found significant clinical variability that was not explained by the type of mutation or steady-state levels of dysferlin. The results are further discussed by Wicklund2 in an accompanying editorial.
There is a well-known decline of specific serum lipids in the time preceding intracranial hemorrhage. Phuah and collaborators3 examine the effect of APOE alleles on this phenomenon. Carriers of an ApoE4 allele had a greater decline in lipids prior to ICH. This effect was specific to total cholesterol and low-density lipoproteins.
Chan et al.4 used a novel approach to examine shared genetic risks for Alzheimer and Parkinson disease. They found that genetic variants increasing risk for Parkinson disease had an effect on AD-associated protein levels in peripheral blood monocytes. The strongest association was found for a variant in the RIT2 locus.
George and friends5 examined the effect of common genetic variants on disease severity in patients with multiple sclerosis. Despite combining several large data sets and several analysis methods, no genetic variant rose to a prespecified significance level. An editorial by Kantarci6 further elucidates the implications of this study.
STUDY FUNDING
No targeted funding reported.
DISCLOSURE
Stefan M. Pulst has served on the editorial boards of Journal of Cerebellum, NeuroMolecular Medicine, Continuum, Experimental Neurology, Neurogenetics, and Nature Clinical Practice Neurology and as Editor-in-Chief of Current Genomics. Dr. Pulst conducts research supported by the NIH, Target ALS, and the National Ataxia Foundation. He has consulted for Ataxion Therapeutics, has received research funding from ISIS Pharmaceuticals, has served on a speakers' bureau for Athena Diagnostics, Inc., and is a stockholder of Progenitor Life Sciences. He has received license fee payments from Cedars-Sinai Medical Center, and has given expert testimony for Hall & Evans, LLC. Dr. Pulst has received publishing royalties from Churchill Livingston (The Ataxias), AAN Press (Genetics in Neurology and Molecular Genetic Testing in Neurology, 2nd–5th editions), Academic Press (Genetics of Movement Disorders), and Oxford University Press (Neurogenetics). Dr. Pulst holds patents for Nucleic acids encoding ataxin-2–binding proteins, Nucleic acid encoding Schwannomin-binding proteins and products related thereto, Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide, Methods of detecting spinocerebellar ataxia-2 nucleic acids, Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto, Schwannomin-binding proteins, and Compositions and methods for spinocerebellar ataxia. He receives an honorarium from the AAN as the Editor of Neurology: Genetics. Go to Neurology.org/ng for full disclosure forms.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Statin treatment and adherence to national cholesterol guidelines after ischemic stroke
APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage
APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly